Stock MEGA MEGA LIFESCIENCES
Add to a list
To use this feature you must be a member
Log inSign up

Company Mega Lifesciences

Equities

MEGA

TH4984010009

Pharmaceuticals

End-of-day quote Thailand S.E.
Other stock markets
 06:00:00 2024-05-02 pm EDT 		5-day change 1st Jan Change
40 THB -1.23% Intraday chart for Mega Lifesciences -3.03% -0.62%
Feb. 23 Transcript : Mega Lifesciences Public Company Limited, 2023 Earnings Call, Feb 23, 2024
Feb. 22 Mega Lifesciences Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Mega Lifesciences Public Company Limited is engaged in manufacturing, marketing, selling and distributing quality pharmaceutical, nutraceutical products and Fast-Moving Consumer Goods (FMCG). Its segments include Maxxcare distribution business, Mega We Care branded products business, and original equipment manufacturer (OEM) business. The Maxxcare distribution business markets, sells and distributes various branded prescription pharmaceutical products, OTC and FMCG products. Its services include warehouse management, collections, including assuming the liability for bad debts, and value-added services. Its Mega We Care branded products business develops, manufactures, markets and sells its own brand of nutraceutical products, prescription pharmaceutical products and OTC products. Mega We Care branded products are sold in a total of 35 countries around the world. Its manufacturing facilities in Thailand and Australia accept various production orders from third-party customers.

Sales per Business

THB in Million2022Weight2023Weight Delta
Brands
52.8 %
8,331 53.1 % 8,287 52.8 % -0.53%
Distribution
45.4 %
7,041 44.9 % 7,115 45.4 % +1.05%
Original Equipment Manufacture
1.8 %
314 2.0 % 279 1.8 % -10.98%

Sales per region

THB in Million2022Weight2023Weight Delta
South East Asia
87.7 %
13,693 87.3 % 13,755 87.7 % +0.46%
Others
6.2 %
1,044 6.7 % 965 6.2 % -7.62%
Sub-Saharan Africa
6.1 %
949 6.0 % 961 6.1 % +1.27%

Managers

Managers TitleAgeSince
Vivek Dhawan CEO
 Chief Executive Officer 62 85-12-31
Thomas Abraham DFI
 Director of Finance/CFO 59 96-12-31
Jonnara Reddy COO
 Chief Operating Officer - -
Deepak Panjwani CMP
 Compliance Officer - -
Manoj Gurbuxani PRN
 Corporate Officer/Principal 49 09-12-31
Sujintana Boonworapat SEC
 Corporate Secretary 51 -

Members of the board

Members of the board TitleAgeSince
Vijay Karwal BRD
 Director/Board Member 53 21-05-12
Kirit Kumar Chimanla Shah FOU
 Founder 70 81-12-31
Chi Yim Kam BRD
 Director/Board Member 67 13-01-31
Shiraz Erach Poonevala BRD
 Director/Board Member 58 13-01-31
Ishaan Shah BRD
 Director/Board Member 35 13-02-28
Vivek Dhawan CEO
 Chief Executive Officer 62 85-12-31
Mechai Viravaidya CHM
 Chairman 83 13-01-31
Sameera Shah BRD
 Director/Board Member 40 13-01-31
Thomas Abraham DFI
 Director of Finance/CFO 59 96-12-31
Nithinart Sinthudeacha BRD
 Director/Board Member 57 23-04-04

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 871,869,508 330,598,620 ( 37.92 %) 0 37.92 %

Shareholders

NameEquities%Valuation
Unistretch Ltd.
49.81 %
434,311,400 49.81 % 500 M ฿
Vivek Dhawan
5.274 %
45,982,716 5.274 % 53 M ฿
Aberdeen Asset Management (Thailand) Co., Ltd.
1.637 %
14,272,873 1.637 % 16 M ฿
Paramjit Singh Sawhney
1.501 %
13,085,395 1.501 % 15 M ฿
Duangnapa Tongsiri
1.478 %
12,883,095 1.478 % 15 M ฿
Anuj Dhawan
0.3787 %
3,301,400 0.3787 % 4 M ฿
Tarun Dhawan
0.3670 %
3,200,000 0.3670 % 4 M ฿
Udit Dhawan
0.3498 %
3,050,000 0.3498 % 4 M ฿
abrdn Australia Ltd.
0.3299 %
2,876,095 0.3299 % 3 M ฿
Ishaan Shah
0.3196 %
2,786,756 0.3196 % 3 M ฿
NameEquities%Valuation
CATAM Asset Management AG
0.0287 %
249,999 0.0287 % 287 769 ฿
SBI Okasan Asset Management Co. Ltd.
0.005724 %
49,905 0.005724 % 57 445 ฿
State Street Global Advisors Ltd.
0.002822 %
24,600 0.002822 % 28 317 ฿
China Asset Management (Hong Kong) Ltd.
0.000459 %
4,000 0.000459 % 4 604 ฿
NameEquities%Valuation
Dimensional Fund Advisors Ltd.
0.000000 %
0 0.000000 % - ฿
State Street Global Advisors Ltd.
0.000000 %
0 0.000000 % - ฿
eQ Varainhoito Oy
0.000000 %
0 0.000000 % - ฿
Threadneedle Investment Services Ltd.
0.000000 %
0 0.000000 % - ฿
Halo Global Asset Management Ltd.
0.000000 %
0 0.000000 % - ฿
Probus Middle East Ltd.
0.000000 %
0 0.000000 % - ฿
DFA Australia Ltd.
0.000000 %
0 0.000000 % - ฿
Eurizon Capital SGR SpA
0.000000 %
0 0.000000 % - ฿

Company contact information

Mega Lifesciences Public Co. Ltd.

909 Ample Tower 9th Floor, Debaratna Road

10260, Bangna

+

http://www.megawecare.com
address Mega Lifesciences(MEGA)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Mega Lifesciences

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
40.5 THB
Average target price
49.56 THB
Spread / Average Target
+22.38%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
MEGA LIFESCIENCES Stock Mega Lifesciences
+1.86% 957M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+29.68% 681B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+20.46% 556B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.35% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.65% 325B
ABBVIE INC. Stock AbbVie Inc.
+3.77% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.47% 235B
NOVARTIS AG Stock Novartis AG
+4.42% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-11.62% 189B
PFIZER, INC. Stock Pfizer, Inc.
-3.79% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. MEGA Stock
  4. Company Mega Lifesciences